ライフサイエンスコーパス: we have demonstrated

1 We have demonstrated a compelling interaction between STAT5A

2 We have demonstrated a lasing regime associated with the form

3 Recently, we have demonstrated beneficial effects of autophagy-activati

4 Using pyridine as a nucleophilic probe, we have demonstrated both experimentally and computationally

5 We have demonstrated dual-color endogenous protein tagging wi

6 We have demonstrated for the first time that the mitochondria

7 Collectively, we have demonstrated, for the first time, that BUP, NBUP, and

8 Here, we have demonstrated increased numbers of B2 lymphocytes in o

9 We have demonstrated label-free and real-time detection of pr

10 We have demonstrated metasurfaces working both in transmissio

11 In the present work, we have demonstrated precise external control of such network

12 We have demonstrated previously that MukB condenses DNA by se

13 We have demonstrated previously that parafascicular thalamic

14 We have demonstrated that (99m)Tc-duramycin specifically accu

15 We have demonstrated that acutely disturbed blood flow with i

16 In addition, we have demonstrated that DeBooster may provide new insights

17 Here, we have demonstrated that deletion of Myc in osteoclasts incr

18 Herein, we have demonstrated that Foxp3+ Tregs potently suppress auto

19 sity of states with density functional theory calculations, we have demonstrated that hydrogen atoms preferentially occup

20 On the background of TH 2 inflammation, we have demonstrated that innate immune cells (notably, airwa

21 the cytoplasmic changes of iron concentration dynamics and we have demonstrated that iron oxide NPs, but not zerovalent

22 Here, we have demonstrated that mice deficient in C-type lectin fam

23 We have demonstrated that microcapsules released Lf in small

24 We have demonstrated that patients with AML exhibit increased

25 Further, we have demonstrated that PhyAsr and PhyAmm have different sp

26 Here, we have demonstrated that SIRT2 depletion results in a decrea

27 Here we have demonstrated that temporary depletion of donor CD4+ T

28 ombin microinjection in the mesenteric circulation of mice, we have demonstrated that the fibrin network of thrombi progr

29 In summary, we have demonstrated that the horizontal transfer of mtDNA fr

30 We have demonstrated that the kinetics of the B cell response

31 Collectively, for the first time to our knowledge, we have demonstrated that the noninvasive measurement of hypo

32 Without losses of the structural advantages, we have demonstrated that the permeation properties of the ho

33 endent counterregulation of MyD88 tyrosine phosphorylation, we have demonstrated that the scaffolding function of recepto

34 odels and sera from clinically well-characterized patients, we have demonstrated that there are dynamic changes in HMGB1

35 ry important outcome of this work is the knowledge that now we have demonstrated that these devices can be successfully o

36 Using retroviral shRNA knockdown, we have demonstrated that these JAK inhibitor-sensitive cells

37 Using a number of complementary techniques, we have demonstrated that these responses are dependent on in

38 a case in point for the physiological roles of the system, we have demonstrated that this multitasking system can be exp

39 Y neurons expressing agouti-related peptide (AgRP) in mice, we have demonstrated that this neuronal population tonically

40 Here, we have demonstrated that type I IFNAR signaling in astrocyte

41 Here we have demonstrated that, although mice with T cell-specific

42 Previously we have demonstrated the feasibility of using metabolic engin

43 We have demonstrated the generality of our approach using two

44 We have demonstrated the generic nature of this method by pre

45 By combining isotope-tracing and genetic experiments, we have demonstrated the presence of an intact de novo biosyn

46 omain peptides are one such assembler, and in previous work we have demonstrated the reversibility of their assembly unde

47 Here, we have demonstrated the selective requirement of the AT1A re

48 We have demonstrated the use of CalQuo (2) by measuring the c

49 In this study, we have demonstrated the use of chemical vapour deposition (C

50 In the work described here, we have demonstrated the use of flock house virus (FHV) as a